The FDA has introduced a new “plausible mechanism pathway” aimed at expediting approval of personalized therapies for rare diseases. The approach, detailed in a Nov. 12 article in The New England ...
Acute kidney injury (AKI) is among the most common organ failures observed in the hospital and can irrevocably alter the trajectory of a patient's short-term and long-term health.1–4 The lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback